70639-77-9

Usage

Uses

Used in Pharmaceutical Synthesis:
2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid is utilized as a key intermediate in the development of pharmaceuticals, particularly for the synthesis of potential drug candidates. Its unique structure and functional groups contribute to the creation of novel compounds with therapeutic potential.
Used in Organic Synthesis:
In the field of organic synthesis, 2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid serves as a versatile building block for the creation of new chemical compounds. Its reactivity and structural features facilitate the formation of diverse organic molecules with various applications.
Used in Anti-inflammatory Applications:
2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid has been studied for its anti-inflammatory properties, making it a promising candidate for the development of anti-inflammatory drugs. Its ability to modulate inflammatory pathways and reduce inflammation-related symptoms offers potential benefits in treating inflammatory disorders.
Used in Antimicrobial Applications:
2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid has also demonstrated antimicrobial properties, indicating its potential use in the development of antimicrobial agents. Its ability to inhibit the growth of microorganisms, including bacteria and fungi, positions it as a valuable asset in the fight against infectious diseases.
Used in Research and Development:
2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid is employed in research and development settings to explore its biological and pharmacological activities further. Its potential role in various therapeutic areas is being investigated, paving the way for the discovery of new treatments and applications.

Upstream product

• 61122-82-5 6-chloroacetyl-1,2,3,4-tetrahydroquinolin-2-one 
• 3279-90-1 6-bromo-3,4-dihydro-1H-quinolin-2-one 
• 83734-39-8 1-<2-(1,2,3,4-tetrahydro-2-oxo-6-quinolyl)-2-oxoethyl>pyridinium chloride 

Downstream Products

• 165591-87-7 8-nitro-6-{4-[N-methyl-N-(2-phenylethyl)amino]-1-piperidinylcarbonyl}-3,4-dihydrocarbostyril 
• 949676-42-0 N-(3,4-dimethylphenyl)-2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxamide 
• 83734-55-8 6-(4-benzyl-1-piperazinylcarbonyl)-3,4-dihydro-2(1H)-quinolinone 
• 741628-65-9 6-{4-[2-(4-methoxybenzoyl)ethyl]-1-piperazinylcarbonyl}-3,4-dihydrocarbostyril 
• 106752-29-8 6-[4-(3,4-Dimethoxy-benzyl)-piperazine-1-carbonyl]-3,4-dihydro-1H-quinolin-2-one 
• 106752-33-4 6-[4-(6-Oxo-6-phenyl-hexyl)-piperazine-1-carbonyl]-3,4-dihydro-1H-quinolin-2-one 
• 106752-32-3 3,4-dihydro-6-<4-(4-oxo-4-phenylbutyl)-1-piperazinylcarbonyl>-2(1H)-quinolinone 
• 106752-31-2 3,4-dihydro-6<4-(3-oxo-3-phenylpropyl)-1-piperazinylcarbonyl>-2(1H)-quinolinone 
• 106752-34-5 6-[4-(2-Phenoxy-ethyl)-piperazine-1-carbonyl]-3,4-dihydro-1H-quinolin-2-one 
• 115091-05-9 6-[4-(2-Oxo-2-phenyl-ethyl)-piperazine-1-carbonyl]-3,4-dihydro-1H-quinolin-2-one 
• 106752-30-1 6-(4-Phenethyl-piperazine-1-carbonyl)-3,4-dihydro-1H-quinolin-2-one 
• 83734-65-0 6-<4-(3,4-dimethoxybenzoyl)-1-piperazinylcarbonyl>-3,4-dihydro-2(1H)-quinolinone 
• 83735-60-8 6-[4-(4-Methoxyphenyl)acetyl-1-piperazinylcarbonyl]-3,4-dihydrocarbostyril 
• 106721-13-5 6-<4-(3-chloro-2-methylphenyl)-1-piperazinylcarbonyl>-3,4-dihydro-2(1H)-quinolinone 

Relevant academic research and scientific papers

Pharmaceutical compounds

This invention relates to compounds of formula (I) where R1 to R12, —W—V—, —X—Y—, m and n have the values defined in claim 1, their preparation and use as pharmaceuticals.

Carbostyril derivatives

Disclosed are carbostyril derivatives and their salts of the formulas STR1 The compounds have anti-peptic ulcer effects, and are useful as a treating agent for curing peptic ulcers in the digestive system, such as ulcers in the stomach and in the duodenum. The compounds particularly have prophylaxis and curing effects for treating chronic ulcers, for example experimental acetic acid-induced ulcers and cautery ulcers, with both low toxicity and few side-effects. Also disclosed are processes for preparing the compounds and for preparing pharmaceutical compositions containing them.